Sohail Jahid

Title: The Innovative Contributions of Sohail Jahid

Introduction

Sohail Jahid is a notable inventor based in Irvine, CA, who has made significant contributions to the field of pharmaceutical chemistry. With a focus on developing inhibitors for the Rho family of GTP-ases, his work has implications for treating various diseases and disorders.

Latest Patents

Sohail Jahid holds 2 patents, showcasing his innovative approach to pharmaceutical compositions. His latest patents include:

1. **Substituted 1,3,5-triazines as inhibitors for a Rho family of GTP-ases** - This invention relates to compounds of Formula (I) or pharmaceutically acceptable salts or solvates thereof. It further discloses a pharmaceutical composition comprising these compounds and their uses, particularly in treating diseases associated with increased RhoJ/Cdc42 levels of expression or function.

2. **Substituted pyrimidines as inhibitors for a Rho family of GTP-ases** - Similar to his previous patent, this invention also relates to compounds of Formula (I) or pharmaceutically acceptable salts or solvates thereof. It details a pharmaceutical composition comprising these compounds and their applications in treating disorders linked to elevated RhoJ/Cdc42 levels.

Career Highlights

Throughout his career, Sohail Jahid has worked with esteemed organizations such as the Fondazione Istituto Italiano Di Tecnologia and the University of California. His experience in these institutions has allowed him to advance his research and contribute to the scientific community.

Collaborations

Sohail has collaborated with notable colleagues, including Marco De Vivo and Anand Ganesan. These partnerships have enriched his research and fostered innovation in his field.

Conclusion

Sohail Jahid's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in the treatment of diseases related to GTP-ases.